This is an academic paper that provides commentary on an emerging treatment model for opioid use disorder (OUD), where medication treatment is delivered through telemedicine. Different telemedicine models for buprenorphine are discussed, as well as strengths and weaknesses of these models. This is especially relevant due to the recent Covid/coronavirus pandemic.